New Delhi: Subject Expert Committee (SEC) has given a recommendation to the Drugs Controller General of India (DCGI) for the use of Bharat Biotech’s COVID-19 vaccine Covaxin for the beneficiaries aged between 2-18 years, the official sources said. Earlier, Dr Sanjay K Rai, a professor at Centre for Community Medicine, All India Institute of Medical […]
"Following the emergency use permission, the company is in a position to meet any production requirement that the government may have at this time,” company officials said
The development came after the UK became the first country in the world to approve a coronavirus vaccine developed by Oxford University and AstraZeneca, even as it battled the new highly contagious variant of the coronavirus.
